Skip to main content
. 2019 Dec 29;9(12):e033353. doi: 10.1136/bmjopen-2019-033353

Table 4.

Constraints and number of mentions (total and by diagnostic group)

Constraints NF1 PSC PAH MFS Total N
Shared aspects named by two diagnostic groups
 Constraints in daily life 3 8 11
Shared aspects named by all four diagnostic groups
 Constraints in personal and social life 4 9 7 5 25
 Constraints in professional life 9 4 3 6 22

Numbers represent the total number of mentions and are displayed for each diagnosis individually as well as across all diagnostic groups; grey cells represent categories, which were mentioned at least once in a diagnostic group.

MFS, Marfan syndrome; NF1, neurofibromatosis type 1; PAH, pulmonary arterial hypertension; PSC, primary sclerosing cholangitis.